WallStreetZenWallStreetZen

NASDAQ: GLUE
Monte Rosa Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Monte Rosa Therapeutics revenue was $14.98M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $9.2M, up 96.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, GLUE annual revenue was $0.0, with N/A growth year-over-year.

GLUE revenue history

Current Revenue
$15.0M
Current Earnings
-$119.4M
Current Profit Margin
-797.3%

Be the first to know when GLUE announces revenue.

GLUE Revenue History By Year

GLUE Yearly RevenueGLUE RevenueGLUE ChangeGLUE Revenue Growth
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A

1 of 1

Monte Rosa Therapeutics Revenue FAQ

What was GLUE's revenue last quarter?

Monte Rosa Therapeutics (NASDAQ: GLUE) reported Q3 2024 revenue of $9.22 million up Infinity% year over year. In the same quarter last year, Monte Rosa Therapeutics's revenue was $0.00.

What was Monte Rosa Therapeutics's revenue in 2023?

Monte Rosa Therapeutics's annual revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.

How much does Monte Rosa Therapeutics make in a day?

Based on Monte Rosa Therapeutics annual revenue for the past four years, GLUE makes an average of $0.00 per day.

What was Monte Rosa Therapeutics's annual revenue growth in the past year?

As of Q4 2024, Monte Rosa Therapeutics's revenue has grown null year over year. Monte Rosa Therapeutics's revenue in the past year totaled $14.98 million.

How much does Monte Rosa Therapeutics make in a year?

Monte Rosa Therapeutics's revenue by year for the past four years is:
  • Monte Rosa Therapeutics's revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.
  • Monte Rosa Therapeutics's annual revenue for Dec 31, 2022 was $0.00, a N/A decrease from 2021.
  • Monte Rosa Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Monte Rosa Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.